Association of adrenal metastases with outcomes in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab in the GETUG-AFU-26 NIVOREN phase II trial.

被引：0
|
作者：
Billon, Emilien
Dalban, Cecile
Oudard, Stephane
Chevreau, Christine
Laguerre, Brigitte
Barthelemy, Philippe
Borchiellini, Delphine
Geoffrois, Lionnel
Negrier, Sylvie
Joly, Florence
Thiery-Vuillemin, Antoine
Gross-Goupil, Marine
Rolland, Frederic
Priou, Frank
Mahammedi, Hakim
Tantot, Florence
Escudier, Bernard
Chabaud, Sylvie
Albiges, Laurence
Gravis, Gwenaelle
机构：
[1] Inst Paoli Calmettes, Marseille, France
[2] Ctr Leon Berard, Lyon, France
[3] Hop Europeen Georges Pompidou, Paris, France
[4] IUCT Oncopole Inst Claudius Regaud, Toulouse, France
[5] Ctr Eugene Marquis, Rennes, France
[6] Inst Cancerol Strasbourg Europe, Strasbourg, France
[7] Univ Cote dAzur, Ctr Antoine Lacassagne, Nice, France
[8] Ctr Alexis Vautrin, Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France
[9] Univ Lyon 1, Ctr Leon Berard, Dept Med Oncol, Lyon, France
[10] Ctr Francois Baclesse, Dept Med Oncol, Caen, France
[11] Univ Hosp Jean Minjoz, Besancon, France
[12] CHU Bordeaux, Hop St Andre, Bordeaux, France
[13] Inst Cancerol Ouest, Dept Med Oncol, St Herblain, France
[14] CHD Vendee Hop Oudairies, La Roche Sur Yon, France
[15] Ctr Jean Perrin, Clermont Ferrand, France
[16] UNICANCER, GETUG Grp, Paris, France
[17] Gustave Roussy, Villejuif, France
[18] Univ Paris Saclay, Gustave Roussy Canc Campus, Villejuif, France
[19] Aix Mareseille Univ, Inst Paoli Calmettes, Marseille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.348
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
348
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
    Billon, Emilien
    Dalban, Cecile
    Oudard, Stephane
    Chevreau, Christine
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Geoffrois, Lionnel
    Negrier, Sylvie
    Joly, Florence
    Thiery-Vuillemin, Antoine
    Gross-Goupil, Marine
    Rolland, Frederic
    Priou, Frank
    Mahammedi, Hakim
    Tantot, Florence
    Escudier, Bernard
    Chabaud, Sylvie
    Albiges, Laurence
    Gravis, Gwenaelle
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 742 - 750
  • [2] Prognosis impact of serous metastases (SMs) in clear cell renal cell carcinoma patients in the GETUG-AFU-26 NIVOREN phase II trial.
    Bardet, Florian
    Dalban, Cecile
    Chevreau, Christine
    Negrier, Sylvie
    Laguerre, Brigitte
    Gravis, Gwenaelle
    Gross-Goupil, Marine
    Oudard, Stephane
    Barthelemy, Philippe
    Ferrero, Jean Marc
    Thiery-Vuillemin, Antoine
    Mahammedi, Hakim
    Narciso, Berangere
    Geoffrois, Lionnel
    Tantot, Florence
    Escudier, Bernard
    Ladoire, Sylvain
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Association of statins and nivolumab activity in patients with metastatic renal cell carcinoma (mRCC): Results from the phase II nivoren-GETUG AFU 26 trial.
    Colomba, Emeline
    Flippot, Ronan
    Dalban, Cecile
    Negrier, Sylvie
    Chevreau, Christine
    Gravis, Gwenaelle
    Oudard, Stephane
    Laguerre, Brigitte
    Barthelemy, Philippe
    Goupil, Marine Gross
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [4] NIVOREN GETUG-AFU 26 translational study: Association of PD-1, AXL, and PBRM-1 with outcomes in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab (N)
    Vano, Yann-Alexandre
    Rioux-Leclercq, Nathalie
    Dalban, Cecile
    Sautes-Fridman, Catherine
    Bougouin, Antoine
    Chaput, Nathalie
    Chouaib, Salem
    Beuselinck, Benoit
    Chevreau, Christine
    Gross-Goupil, Marine
    Negrier, Sylvie
    Laguerre, Brigitte
    Borchiellini, Delphine
    Colina-Moreno, Irelka
    Fridman, Wolf-Herman
    Chabaud, Sylvie
    Tantot, Florence
    Monteiro, Janice Barros
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study
    Mourey, Loic
    Rainho, Larissa Tames
    Dalban, Cecile
    Carril-Ajuria, Lucia
    Negrier, Sylvie
    Chevreau, Christine
    Gravis, Gwenaelle
    Thibault, Constance
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Tantot, Florence
    Chaput, Nathalie
    Naigeon, Marie
    Teixeira, Marcus
    Escudier, Bernard
    Flippot, Ronan
    Albiges, Laurence
    EUROPEAN JOURNAL OF CANCER, 2024, 201
  • [6] Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial
    Courcier, J.
    Dalban, C.
    Laguerre, B.
    Ladoire, S.
    Barthelemy, P.
    Oudard, S.
    Joly, F.
    Mescam, G. Gravis
    Chevreau, C. M.
    Geoffrois, L.
    Deluche, E.
    Rolland, F.
    Topart, D.
    Culine, S.
    Negrier, S.
    Mahammedi, H.
    Tantot, F.
    Escudier, B.
    Flippot, R.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S560 - S560
  • [7] Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial
    Courcier, Jean
    Dalban, Cecile
    Laguerre, Brigitte
    Ladoire, Sylvain
    Barthelemy, Philippe
    Oudard, Stephane
    Joly, Florence
    Gravis, Gwenaelle
    Chevreau, Christine
    Geoffrois, Lionel
    Deluche, Elise
    Rolland, Frederic
    Topart, Delphine
    Culine, Stephane
    Negrier, Sylvie
    Mahammedi, Hakim
    Tantot, Florence
    Jamet, Antoine
    Escudier, Bernard
    Flippot, Ronan
    Albiges, Laurence
    EUROPEAN UROLOGY, 2021, 80 (03) : 325 - 329
  • [8] Validation of the lung immune prognostic index (LIPI) in patients with metastatic renal cell carcinoma treated with nivolumab in the GETUG-AFU 26 NIVOREN trial
    Lavaud, Pernelle
    Dalban, Cecile
    Negrier, Sylvie
    Chevreau, Christine
    Gravis, Gwenaelle
    Oudard, Stephane
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Goupil, Marine Gross
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Mezquita, Laura
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] Efficacy and safety of nivolumab in renal cell carcinoma patients with BONE metastases: Results of the GETUG: AFU 26 nivoren multicenter phase II study.
    Velev, Maud
    Dalban, Cecile
    Chevreau, Christine
    Gravis, Gwenaelle
    Negrier, Sylvie
    Laguerre, Brigitte
    Gross-Goupil, Marine
    Ladoire, Sylvain
    Ferrari, Victoria
    Geoffrois, Lionnel
    Curcio, Hubert
    Priou, Frank
    Thomas, Quentin Dominique
    Mione, Cecile
    Barthelemy, Philippe
    Tantot, Florence
    Escudier, Bernard
    Chabaud, Sylvie
    Albiges, Laurence
    Thibault, Constance
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] Baseline cytokine levels according to the line of treatment in patients with metastatic clear cell renal cell carcinoma treated with nivolumab: NIVOREN GETUG-AFU 26 translational study
    Rainho, L. T.
    Albiges, L.
    Flippot, R.
    Ajuria, L. Carril
    Dalban, C.
    Escudier, B.
    Naigeon, M.
    Desnoyer, A.
    Teixeira, M.
    Chaput-Gras, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S1027 - S1027
12345